Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Deep Track Capital

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 20
Average round size
info
The average size of a deal this fund participated in
$84M
Portfolio companies 20
Lead investments 0
Exits 9
Key employees Soon
Stages of investment
Private Equity

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Deep Track Capital:
Typical Co-investors
Deep Track Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Deep Track Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerated Technologies Partners New York, New York, United States
Aquiline Technology Growth New York, New York, United States
CareerOne Australia, New South Wales, Sydney
Foley Ventures Milwaukee, United States, Wisconsin
Guotai Venture Capital China, Jiangsu, Nantong
Insight Technology Capital Partners -
ITUARI Teknokent -
La Nevera Roja.com Community of Madrid, Madrid, Spain
Leonardo Venture Baden-Wurttemberg, Germany, Mannheim
LITTLEROCK Düsseldorf, Germany, Nordrhein-Westfalen
Rongxi Venture China, Jinshan District
South Suez Capital Grand Baie, Mauritius, Riviere du Rempart
Stingray Canada, Montréal, Quebec
Tab The Momentum Seoul, Seoul-t'ukpyolsi, South Korea
Techweek Chicago, Illinois, United States
Uber Alumni Syndicate -
Xalisco Ventures Pennsylvania, Pittsburgh, United States
Xinjiang Yuesheng Guquan Touzi Youxian Gongsi China, Ürümqi, Xinjiang
Zongheng Tianxia China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Lusaris Therapeutics

Biotechnology
Therapeutics
$60M02 Nov 2022 Boston, Massachusetts, United States

Immunic

Biotechnology
Life Science
Medical
Therapeutics
$60M10 Oct 2022 San Diego, California, United States

Immunovant

Biotechnology
Pharmaceutical
$75M04 Oct 2022 New York, New York, United States

Allakos

Biopharma
Biotechnology
Health Care
Therapeutics
$150M19 Sep 2022 California, United States

Abivax

Biotechnology
$58M02 Sep 2022 Paris, Ile-de-France, France

Heron Therapeutics, Inc.

Biotechnology
Health Care
Therapeutics
$76M09 Aug 2022 Redwood City, California, United States

Structure Therapeutics

Biopharma
Biotechnology
Genetics
Health Care
Medical
$33M03 Aug 2022 Shanghai, Shanghai, China

ShouTi

Biotechnology
Health Care
Medical
Pharmaceutical
Product Research
$33M01 Aug 2022 Shanghai, China

Carmot Therapeutics

Biotechnology
Health Care
Therapeutics
$160M26 Jul 2022 San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Deep Track Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: